Therefore, the data suggest that GSH is effective in counteracting the nephrotoxic side effects of CDDP, while the three administration methods were observed to have no significant differences from each other
Since they are not FDA-approved, they do not have standardized FDA-required labeling, including side-effect warnings, boxed warnings, or risk evaluation and mitigation strategies that apply to approved drugs
Tirzepatide is technically a dual agonist GLP-1/GIP (glucose-dependent insulinotropic polypeptide) Liraglutide (Saxenda and Victoza) Each of these works in a similar way, but differs in terms of how long they stay active in the body and how they interact with different receptors
Administration Route by Peptide Type When Injectable GHK-CU Makes Sense The injectable form provides systemic benefits that topical cannot achieve: Whole-body tissue regeneration effects Internal organ support Consistent blood levels Better bioavailability Combined with other injectable peptides When Topical Makes Sense Topical application excels for: Targeted skin treatment Hair and scalp applications Those avoiding injections Combination with skincare routines Localized wound healing For maximum benefit, some protocols use both injectable GHK-CU for systemic effects and topical copper peptides for targeted skin benefits
J Am Acad Dermatol 49(1):9698